Collegium Pharmaceutical Inc
NASDAQ:COLL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
US |
|
Constellation Energy Corp
NASDAQ:CEG
|
US |
|
A
|
Andean Precious Metals Corp
XTSX:APM
|
CA |
|
Playtika Holding Corp
NASDAQ:PLTK
|
IL |
|
M
|
MTN Group Ltd
JSE:MTN
|
ZA |
|
S
|
Simmtech Co Ltd
KOSDAQ:222800
|
KR |
|
Anglogold Ashanti PLC
F:HT3
|
UK |
|
Bourse Direct SA
F:BD6
|
FR |
|
Boat Rocker Media Inc
TSX:BRMI
|
CA |
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
IE |
|
Gentherm Inc
NASDAQ:THRM
|
US |
|
Redline Communications Group Inc
TSX:RDL
|
CA |
Wall Street
Price Targets
COLL Price Targets Summary
Collegium Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for
COLL
is 55.25 USD
with a low forecast of 44.44 USD and a high forecast of 63 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is COLL's stock price target?
Price Target
55.25
USD
According to Wall Street analysts, the average 1-year price target for
COLL
is 55.25 USD
with a low forecast of 44.44 USD and a high forecast of 63 USD.
What is Collegium Pharmaceutical Inc's Revenue forecast?
Projected CAGR
-2%
The
compound annual growth rate
of Collegium Pharmaceutical Inc's revenue for the next 3 years is
-2%.
What is Collegium Pharmaceutical Inc's Operating Income forecast?
Projected CAGR
20%
The
compound annual growth rate
of Collegium Pharmaceutical Inc's operating income for the next 3 years is
20%.
What is Collegium Pharmaceutical Inc's Net Income forecast?
Projected CAGR
37%
The
compound annual growth rate
of Collegium Pharmaceutical Inc's net income for the next 3 years is
37%.
